Novolyze

Novolyze

Novolyze

Harmless "surrogate" bacteria that mimic the inactivation of foodborne pathogens, used at industrial & pilot scale to validate and optimize food processes.
Type
B2c
Founded
2012
Raised
$3.7M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
€2,200,000
Seed fund - 2018
Family Office Anaxago
€900,000
Undisclosed
Team Size
1–10
Employees

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Novolyze makes some noise.